15 Mar

Oracle Stock Fell despite Q3 Earnings and Revenue Beat

WRITTEN BY Scarlett Ness FEATURED IN Post-Release Earnings Reports and Tech & Comm Services

Oracle stock down 3.9% after hours

Software and cloud services giant Oracle (ORCL) was down as much as 4% in extended trading on Thursday, even though the company reported better-than-expected numbers in the third quarter of fiscal 2019, which ended in February. Oracle easily exceeded Wall Street expectations on both earnings and revenues in the third quarter driven by growth momentum in its cloud services and license segment unit. However, Oracle’s revenues declined year-over-year mainly due to a strong dollar, which pulled down the stock in after-hours trading.

In fact, strong US currency will likely continue to dent the revenues in the fourth quarter by 3%. The company expects fourth-quarter of fiscal 2019 revenue to remain flat to down 2% YoY (in US dollars). Analysts are expecting fourth-quarter revenues of $11.06 billion, down ~1.8% YoY.

Oracle Stock Fell despite Q3 Earnings and Revenue Beat

Oracle’s Q3 results

Oracle reported adjusted earnings of $0.87 per share in the third quarter. Earnings beat expectations of $0.84 per share by 3.6% and the year-ago number by 8%.

Revenues of $9.62 billion also beat the expectations of $9.59 billion in the quarter by 0.3%. Oracle has beaten analysts’ revenue expectations in 11 out the last 18 straight quarters. However, revenues declined slightly by 0.7% from the year-ago quarter due to currency headwinds.

Peers’ performance

Oracle stock closed down 0.02% to $53.05 but gained nearly 18% in the year-to-date period as of March 14. In the software industry, Oracle’s peers IBM (IBM) and Symantec (SYMC) gained 23.5% and 21.7%, respectively, while Microsoft (MSFT) and FireEye (FEYE) increased 13.3% and 3.9%, respectively, in the same period.

Latest articles

Hibbett Sports (HIBB) stock surged 22.3% as of 1:54 PM ET today as the company reported impressive results for fiscal 2019's fourth quarter, which ended on February 2.

Wall Street analysts expect a potential upside of 21.63% for Alexion Pharmaceuticals based on the stock's closing price on March 21.

Today, we got another round of dismal data points from Europe (VGK)(EZU). According to a Markit survey, Germany’s (EWG) March PMI Composite Output Index fell to a 69-month low of 51.5.

On March 21, US crude oil’s implied volatility was 24.9%, which was 6.7% below its 15-day average. Usually, lower implied volatility supports oil prices.

The overall cannabis sector took a hit today amid the broader market's declines. The volatility index (VIX) jumped 17.9%, and the cannabis sector is more sensitive than the market.

The tech-heavy NASDAQ Composite Index (QQQ) is on track to post its 12th weekly gain in 13 weeks.